+Vote!
PR News Wire (Free subscription) | 21/11/2008
HOUSTON, Nov. 21 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: ) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Vice President, Finance and Chief Financial Officer, will present at the Piper Jaffray 20th Annual Health Care Conference in New York on Tuesday, December 2, 2008 at 1:00 PM EST. The conference session and webcast will be audio only and...
+Vote!
PR News Wire (Free subscription) | 19/11/2008
-- Net sales of $36.0 million, a 24% increase from $28.9 million,
-- Net U.S. product sales attributable to the epilepsy indication
increased by an estimated 32% to $28.6 million, unit sales grew by 11%,
-- Gross profit margin increased to 85.6% from 84.2%,
-- Adjusted net income of $3.74 million (excluding a gain of $4.61 million
on early extinguishment of debt), and net income of $8.35 million
...
+Vote!
PR News Wire (Free subscription) | 04/11/2008
HOUSTON, Nov. 4 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:
CYBX) today announced that the company will report financial results for
the second quarter ended October 24, 2008 of its fiscal year ending April
24, 2009 on Wednesday, November 19, 2008 at 5:00 PM EST. The company will
conduct a conference call to discuss those results on Thursday, November
20, 2008 at 9:00 AM EST.
Fiscal...
+Vote!
PR News Wire (Free subscription) | 31/10/2008
Company Reaffirms Fiscal Year 2009 Revenue Guidance
HOUSTON, Oct. 31 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:
CYBX) today announced that the Centers for Medicare and Medicaid Services
(CMS) has published the 2009 CMS Outpatient Prospective Payment System
(OPPS) Final Rule and Ambulatory Payment Classification (APC) rate for VNS
Therapy. The final rule, which goes into effect January...
+Vote!
soulful sepulcher (Free subscription) | 31/10/2008
... Carolina, Charleston, SC, USA 7VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA 8 Cyberonics Inc., Houston, TX, USA -- "Currently available therapeutic interventions for treatment-resistant depression, including switch, combination, and augmentation strategies, are less than ideal. Observations of mood elevation during vagus nerve stimulation (VNS) therapy for pharmacoresistant...
+Vote!
Global Financial News (Free subscription) | 21/11/2008
... also added to the Conviction Buy List. Intuit (NASDAQ: INTU ) was raised to Buy from Sell at UBS. Cyberonics (NASDAQ: CYBX ) was lifted to Buy from Neutral at Piper Jaffray. Analyst downgrades: Baird downgraded Autodesk (NASDAQ: ADSK ) to Neutral from Outperform and lowered its target to $20 from $31 following the company's weak Q4 guidance. Shares were also downgraded to Underperform from...
+Vote!
DeepMarket Stock Market Blog (Free subscription) | 09/11/2008
Seasonal Patterns found for the following stocks: Champps Entertainment Inc (CMPP) over the next 10 trading days. Look at the seasonal patterns for Champps Entertainment Inc in context. Csk Cp (CSKKY) over the next 8 trading days. Look at the seasonal patterns for Csk Cp in context. Cyberonics Inc (CYBX) over the next 9 trading days. [...]
